Statistical methods for clinical trials
Involvement in clinical trials
Members of the Division of Biostatistics are designated as responsible biometricians in a large number of phase I - III cancer clinical trials. This includes participation in the study design, calculation of power and sample size, development of statistical analysis plans, as well as the biometric analysis and final reporting and publication. In particular, we are the Biometric center for the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG), the German-speaking Myeloma-Multicenter Group (GMMG) and the German Multicenter Study Group on Adult Acute Lymphoblastic Leukemia (GMALL). In addition, we support the NCT Trial Center and the Amyloidosis Center at the Heidelberg University Hospital in clinical and registry trials. We are responsible biometricians for trials and registries run by the Hopp Children's Cancer Center KiTZ. With our activities we are involved in practice changing clinical trials.
Motivated by our involvement as responsible statisticians for a large number of clinical trials, we develop methods for design and analysis of clinical trials, both in the Bayesian framework as well as the frequentist setting.